Run time: 83m

  1      0

2019 AABB Annual Meeting On-Demand

MN3-26: Proficiency Testing: The Who, What, When, and Why

Oct 21, 2019 2:00pm ‐ Oct 21, 2019 3:30pm

Expiration Date: Dec 31, 2021

Credits: None available.

Standard: $25.00
Members: $20.00


In this session, members of the College of American Pathologists (CAP) Transfusion Medicine, Apheresis, and Cellular Therapy Committee will review the current state of proficiency testing (PT) regulations and objectives. Issues with specific PT surveys will be discussed, including transfusion-related cell counts and antibody titers.

Learning Objectives:

  • Define the regulations that require proficiency testing (PT), examples of tests that are graded versus ungraded, and the implications of regulations.
  • Appreciate common errors seen in PT, using Transfusion-Related Cell Counting as an example.
  • Identify difficulties in comparing antibody titer results between laboratories as highlighted by PT.



  • Matthew Karafin, M.D., M.S. : <p>Nothing to Disclose</p>
  • Yara Park, MD : <p>Nothing to Disclose</p>
  • Jeffrey Winters, MD : <p>Fresenius Kabi: Consultant</p>
  • Nicole Zantek, MD, PhD : <p>Boston Scientific: Stock Shareholder (self-managed), Spouse employee  I  ENDO International PLC: Stock Shareholder (self-managed)  I  Stago Diagnostics: Honoraria  I  North American Specialized Coagulation Laboratory Association: Executive Board</p>

Credits Available

MN3-26: Proficiency Testing: The Who, What, When, and Why Evaluation

You must be logged in and own this session in order to post comments.